MMC in ONS decompression.
Kersten
R C
RC
Kulwin
D R
DR
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000009:adverse effects* / Q000627:therapeutic use; D009186:Myelin Sheath; D009900:Optic Nerve / Q000187:drug effects*; D009901:Optic Nerve Diseases / Q000188:drug therapy / Q000209:etiology; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy; D010211:Papilledema / Q000188:drug therapy / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011559:Pseudotumor Cerebri / Q000188:drug therapy* / Q000209:etiology; D012163:Retinal Detachment / Q000139:chemically induced / Q000188:drug therapy; D012166:Retinal Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D015423:Scleritis / Q000139:chemically induced* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D000903:Antibiotics, Antineoplastic; D016685:Mitomycin; D011241:Prednisone